Observations on parasitic gastroenteritis and bronchitis in grazing calves: untreated calves

Serological lessons from the bovine lungworm Dictyocaulus viviparus: Antibody titre development is independent of the infection dose and reinfection shortens seropositivity

Infections with the bovine lungworm Dictyocaulus viviparus, the causative agent of parasitic bronchitis, are accompanied by substantial economic losses due to impacts on production, clinical respiratory disease or even death of diseased cattle. To detect lungworm antibodies in cattle, an enzyme-linked immunosorbent assay (ELISA) based on recombinant major sperm protein (MSP) has been developed. However, it remained unknown whether the infection dose influences antibody levels, and how acquired immunity influences antibody level patterns during reinfections. The latter may lead to low within-herd seroprevalence and thus to negative MSP-ELISA results in examination of bulk tank milk (BTM). Thus, infection experiments with 12 different doses ranging from 10 to 3000 D. viviparus larvae were performed to assess whether the antibody response is dose-dependent. Second, the impact of reinfections on the antibody response was evaluated in infection experiments, and third, antibody patterns in dairy cows during naturally occurring reinfections were assessed in a longitudinal field study based on individual milk samples. Results of this study demonstrate that the rise in MSP antibodies during first infection is dose-independent at infection doses of 25 lungworm larvae and above. However, following reinfections the magnitude and duration of the MSP antibody response are reduced or lacking, depending on the interval to reinfection. The field study revealed short periods of seropositivity as a common pattern in dairy cows subjected to natural D. viviparus reinfections. Low within-herd seroprevalence in dairy herds can thus be a result of continuous reinfections. Low infection doses should not be a barrier to serodiagnosis of lungworm infection in first-time infected cattle.

Gastrointestinal nematode infections of first-grazing season calves in Western Europe: general patterns and the effect of chemoprophylaxis

Research on the prevention of gastrointestinal nematode infections of cattle has mainly concentrated on comparing a specific chemoprophylactic treatment system to an untreated control group on a particular farm. Here, the results from analysis of 85 studies involving over 2000 first grazing season (FGS) calves put onto pasture for at least 4 months from late spring/early summer over a 26-year period in 13 countries in Western Europe are presented. Both control and chemoprophylactic treated FGS calf groups were considered. All chemoprophylactic systems (slow- and pulse-release boli, strategic treatments) were given early in the grazing season. Two general infection levels emerged--'sub-clinical' (32 studies) and 'clinical' (53 studies). The 'sub-clinical' infections were characterised by no clinical symptoms of parasitic gastroenteritis (PGE) being observed in the control groups. Mean faecal egg counts in the 'clinical' control groups were significantly higher than those for 'sub-clinical' control groups for almost the entire season with overall peaks of 275 and 100 EPG respectively. Maximum pasture larval counts were also significantly higher in the 'clinical' control groups with 44% of 'clinical' pastures > 10,000 L3 kg(-1) dry herbage by the end of the FGS, compared to only 15% of 'sub-clinical' pastures. There was a significant positive relationship between log transformed worm burdens from tracers put onto pastures for 2 weeks and the corresponding pasture larval count. No evidence of density dependence in tracer worm burden was observed. Weight gains in the 'clinical' control groups (375 g/day) were significantly lower than those of the 'sub-clinical' control groups (530 g/day). No symptoms of PGE were observed in any of the chemoprophylactic treated groups, but in those studies with an outbreak of PGE in the control group, the treated groups had significantly higher faecal egg and pasture larval counts than treated groups in 'sub-clinical' studies. The overall weight gain in chemoprophylactic treated calves in 'clinical' studies (600 g/day) was significantly lower than the chemoprophylactic treated calves in 'sub-clinical' studies (690 g/day), and was not significantly different from the weight gain of control calves in 'sub-clinical' studies. These results indicate that on heavily infected pastures, chemoprophylaxis will prevent PGE, but calves will still suffer production losses.

Effect of naturally occurring nematode infections on growth performance of first-season grazing calves

Liveweight of calves on 89 dairy farms was measured at the end of the grazing season and related per herd to the level of exposure to nematode infection during the grazing season. There were significant between-herd variations in antibody titres against Ostertagia spp., Cooperia spp. and Dictyocaulus viviparus as well as in pepsinogen values. All but six herds (93.1%) had gastrointestinal nematode infections, as measured by faecal egg counts in September. Faecal samples of 17 herds (19.3%) contained lungworm larvae in September. Liveweight of calves per herd deviated from -68.1 kg to +84.1 kg from the age-adjusted population mean after their first grazing season. Growth performance up to the time of liveweight measurements was significantly correlated negatively with several serological and parasitological parameters. Data could be fitted by means of both linear and segmented curvilinear regression. Antibody titre against Cooperia spp. and gastrointestinal nematode egg output measured in September accounted for 3.1% (P less than 0.10) and 6.7% (P less than 0.05), respectively, of the variation in growth performance among herds. Certain infection parameters, when combined, accounted for 9.2% of this variation; these were antibody titre against Cooperia spp. and larval counts for both gastrointestinal nematodes and lungworm. Adding certain management factors to these infection parameters resulted in a model explaining 27.6% of the observed variation in growth performance among herds. These factors were supplementary feeding, lungworm vaccination, anthelmintic treatment at housing, date of housing and herd age.

A mathematical model of the population biology of Ostertagia ostertagi in calves and yearlings

A mathematical model of the population biology of Ostertagia ostertagi is described. The model assumes that the natural control and regulation of parasite numbers is mediated by four processes: the effect of climate on the development and survival of the free-living stages; changes in the rate of establishment of the infective larvae, and density-dependent variations in parasite survival and fecundity. The model is used to compare the course of the infection in two groups of calves. One group is assumed to have been reared under conditions typical of S.E. England and the other under conditions typical of Louisiana, USA. The more general behaviour of the model is discussed in the context of sensitivity analysis. The model is an excellent mimic of the epidemiology of bovine ostertagiasis. It can be used as a simple screening procedure to help determine which of many possible anthelmintic control strategies should be selected for more detailed examination in the field, and it provides a theoretical framework within which ideas concerning the epidemiology of parasitic gastroenteritis can be assessed and refined.

Efficacy of morantel tartrate in a sustained release bolus on the control of subclinical gastrointestinal parasitism in first-year grazing dairy replacements

Thirty-four heifers (24 Holstein, 8 Ayrshire, 2 Jersey) and 12 Holstein steer calves were grouped into 23 blocks of 2 animals each according to breed, sex, and body weight. Animals in each block were randomly assigned to control or treated groups. The treated group received an anthelmintic bolus containing morantel tartrate before they were permitted access to pasture. A 2.6 ha pasture was divided in half with a double fence; the resulting two pastures had separate feed and water troughs. Steer calves were slaughtered upon termination of the trial to ascertain gastrointestinal parasite burdens. Two worm-free tracer calves were placed on each pasture every 2 mo and slaughtered after 4 wk of grazing to determine parasite infectivity of pastures. Herbage samples were obtained monthly and analyzed for infective larvae. The trial was conducted for 141 d during the grazing season. Treatment resulted in 90% reduction in infective larvae on pasture, 74% reduction in fecal worm-eggs, 91% reduction in adult worm burdens, and a trend toward reduced worm burdens in tracer calves by 52%. An overall average daily gain of .68 and .88 kg was obtained for control and treated animals. Reproductive data for the heifers remaining in the herd from the trial showed that treatment resulted in 44 less days to first breeding.

The use of the morantel sustained release bolus in second-season grazing cattle

The efficacy of the morantel sustained release bolus in controlling gastrointestinal helminth infection in second-season grazing cattle was investigated on a total of seven farms in southeast England. On each farm only animals which had grazing experience from the previous summer pasturing season were used. The animals on each farm were allotted into two equal groups and turned out onto divided pastures of equal size. All the cattle in one group received a bolus at turnout while the cattle in the other group remained as nontreated controls. Assessment of the efficacy of treatment was based on comparisons of faecal worm egg output, herbage larval counts, weight gain, and the incidence of clinical parasitic gastroenteritis during the grazing season. Use of the morantel sustained release bolus led to the cessation of worm egg excretion in bolus-treated cattle during the early part of the grazing season thereby preventing a subsequent buildup of infective larvae on pasture. Although the overall results from worm egg and herbage larval counts demonstrated little measurable effect of treatment, clinical parasitic gastroenteritis was prevented in two trials where control animals became clinically affected by parasitism. Overall, the bolus-treated animals outperformed the controls by a mean of 15.1 kg (P less than 0.001).